Author:
Khan M Y,Gruninger R P,Nelson S M,Klicker R E
Abstract
The in vitro activity of a new oral antimicrobial agent, norfloxacin (MK-0366), was compared with those of nalidixic acid, nitrofurantoin, co-trimoxazole, trimethoprim, sulfamethoxazole, cinoxacin, tetracycline, ampicillin, carbenicillin, and cephalexin against 628 urinary bacterial isolates. Norfloxacin was the most active antimicrobial agent tested against the gram-negative bacilli. It was less active than a few of the other antimicrobial agents against enterococci and Staphylococcus aureus.
Publisher
American Society for Microbiology
Subject
Infectious Diseases,Pharmacology (medical),Pharmacology
Reference3 articles.
1. Comparative activities of AM-715 and pipemidic and nalidixic acids against experimentally induced systemic and urinary tract infections;Hhral K.;Antimicrob. Agents Chemother.,1981
2. In vitro antibacterial activity of AM-715, a new nalidixic acid analog;Ito A.;Antimicrob. Agents Chemother.,1980
3. An inocula replicating apparatus for routine testing of bacterial susceptibility to antibiotics;Steers E.;Antibiot. Chemother.,1959
Cited by
58 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献